Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2003
03/27/2003US20030060516 Method of using lectins for contraception, prophylaxis against diseases transmittable by sexual contact, and therapy of such diseases, and apparatus for administering lectins
03/27/2003US20030060512 Modulation of inflammation related to columnar epithelia
03/27/2003US20030060490 Method for the treatment and prevention of urinary stone disease
03/27/2003US20030060459 Diamines as modulators of chemokine receptor activity
03/27/2003US20030060449 Nutraceuticals for treatment of leukemia and solid tumors
03/27/2003US20030060443 Inhibition of apoptosis by the expression of antisense RNA of caspase-3
03/27/2003US20030060442 Immunostimulatory cyktokines include interleukins as antitumor agents, dervived from dendritic cells modified via viral vector transduction/centrifugation
03/27/2003US20030060438 Adminstering oligonucleotides or analogs that are complementary to a portion of nucleic acid in the nk-1 receptor biosynthetic pathway to the extent that production is modulated
03/27/2003US20030060437 Antisense modulation of dual specific phosphatase 5 expression
03/27/2003US20030060436 Treatment of parkinson's disease with oligonucleotides
03/27/2003US20030060435 Method of cancer treatment by p53 protein control
03/27/2003US20030060434 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
03/27/2003US20030060433 Reducing the severity of cancer
03/27/2003US20030060432 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers
03/27/2003US20030060428 Bicyclo (3.2.1)octane in a double ring system having a basic chemical skeletal of a kaurene structure that responds only at elevated plasma glucose concentrations
03/27/2003US20030060425 Immune modulation method using steroid compounds
03/27/2003US20030060418 Serine protease inhibitors
03/27/2003US20030060416 Blk genes, gene products and uses thereof in apoptosis
03/27/2003US20030060415 Internal entry, such as through an atrium or ventricle, or can be by an external entry through the chest wall; cardiovascular therapeutics
03/27/2003US20030060413 Derivatives of pseudo-peptides, their preparation and their biological uses
03/27/2003US20030060412 Dissolving in aqueous base or in aqueous acid, neutralized to a pH at which substantially no amino acid racemization; stimulate insulin secretion for the treatment of diabetes, obesity
03/27/2003US20030060411 A mixture of active blood-coagulation Factor VII and Factor X for treating hemorrhage blood disorders
03/27/2003US20030060410 Use of HMG fragments as anti-inflammatory agents
03/27/2003US20030060409 Polynucleotide encoding a novel human G-protein coupled receptor, HGPRBMY25, expressed highly in immune-related tissues
03/27/2003US20030060408 Metal-binding compounds and uses therefor
03/27/2003US20030060407 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/27/2003US20030060406 Nucleotide sequence that encodes an amino acid sequence by culturing the host cell for expression of polypeptide; agonist or antagonist
03/27/2003US20030060405 Administering to the subject a composition containing the amino acid sequence hexapeptide
03/27/2003US20030060404 Storage stability, long shelf life; a solution has anti-microbial activity without additional anti-microbial agent; growth hormones for cats and dogs; veterinary medicine
03/27/2003US20030060403 Hepatocyte growth factor manufactured by gene recombination; treatment of dementia, senile dementia of Alzheimer type, cerebral stroke, and cerebral infarction
03/27/2003US20030060402 Novel cyclosporin galenic forms
03/27/2003US20030060401 Genetic engineered drug
03/27/2003US20030060399 A heat shock protein 20 (HSP20)-derived polypeptides for treating or inhibiting smooth muscle vasospasm, smooth muscle cell proliferation, migration, and vasoconstriction
03/27/2003US20030060398 Neuronal rescue agent
03/27/2003US20030060397 Method of treating and preventing acute neural lesions with substances that modulate the expression or function of a protein involved in the cell cycle and pharmaceutical preparations containing such substances
03/27/2003US20030059944 Method for expression of small antiviral RNA molecules within a cell
03/27/2003US20030059923 Polynucleotide encoding a novel human potassium channel alpha-subunit, K+alphaM1, and variants thereof
03/27/2003US20030059922 Sphingosine1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
03/27/2003US20030059921 Novel clot-specific steptokinase proteins possessing altered plasminogen activation characteristics and a process for the preparation of said proteins
03/27/2003US20030059919 Novel human 39228, 21956, 25856, 22244, 8701, 32263, 50250, 55158, 47765, 62088, 50566, and 48118 molecules and uses therefor
03/27/2003US20030059918 Regulation of human serine/threonine protein kinase
03/27/2003US20030059916 IRAK-4: compositions and methods of use
03/27/2003US20030059912 Hybrid ptorin for use in treating allergies and controlling immunogical response
03/27/2003US20030059911 Modulator of transcription factor activity for use in the treatment of immune response, stress responses, inflammation or apoptotic disorders
03/27/2003US20030059909 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative disorders
03/27/2003US20030059908 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cancer and cardiovascular disorders
03/27/2003US20030059898 Expression vector for use as gene transfer tool in genetic engineering
03/27/2003US20030059896 Nucleotide sequences coding polypeptide for use in the diagnosis and detection of chlamydial infcetions
03/27/2003US20030059895 Protein for use as diagnostic and therapeutic tool in cancer treatment
03/27/2003US20030059894 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of lyme disease
03/27/2003US20030059892 Peptide for use in the diagnosis and treatment of inflammatory bowel disease
03/27/2003US20030059891 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof
03/27/2003US20030059890 Protein for use as antiinflammatory, antiproliferative and antipyretic agents
03/27/2003US20030059887 Ligand for use in the treatment of tumors, injuries, thrombosis, atherosclerosis and inflammatory diseases
03/27/2003US20030059881 Polypeptide for use in the treatment of inflammatory, autoimmune and cancer diseases
03/27/2003US20030059877 Human cystine knot polypeptide
03/27/2003US20030059875 Nucleotide sequences coding polypeptide for use in the treatment prevention and diagnosis of inflammatory blood and cancer disorders
03/27/2003US20030059874 Polypeptide for use in the treatment of autoimmune, inflammatatory, arthritic, atherosclerotic, allergenic, dermatitis, urticaria, adult respiratory distress syndrome, asthma, rhinitis, eczema and infections
03/27/2003US20030059871 Hematopoietin receptors HPR1 and HPR2
03/27/2003US20030059869 Novel G protein-coupled receptor, GAVE3
03/27/2003US20030059865 Oligo(ethylene glycoll)-terminated 1,2-dithiolanes and their conjugates useful for preparing self-assembled monolayers
03/27/2003US20030059863 N-terminally truncated HER-2/neu protein as a cancer prognostic indicator
03/27/2003US20030059856 Detection of modulator of receptor binding activity; obtain sample containing receptor, incubate with test agent and ligand, monitor binding activity of ligand, adjusment in binding activity indicates modulator
03/27/2003US20030059852 Detecting modulators of integrin activity; obtain sample containing integrin, incubate with test compound, monitor adjustment in integrin activity, adjustment in integrin activity indicates modulator
03/27/2003US20030059838 Monoclonal antibody for use as diagnostic tool in gene therapy
03/27/2003US20030059833 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and nervous system disorders
03/27/2003US20030059832 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and nervous system disorders
03/27/2003US20030059831 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and nervous system disorders
03/27/2003US20030059829 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and skin disorders
03/27/2003US20030059828 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and skin disorders
03/27/2003US20030059812 HDAC9 polypeptides and polynucleotides and uses thereof
03/27/2003US20030059805 Nucleotide sequences coding polyeptide for use in the treatment of growth disorders in humans
03/27/2003US20030059802 Nucleotide sequences coding polypeptide for use in the prevention and treatment of infection of gut and intestine; for use aide in digestion and nutrient absorption
03/27/2003US20030059796 Detecting genes associated with controlling angiogenesis; obtain and culture endothelial cells, isolate ribonucleic acids, amplified or reduced concentrations of preferenial ribonucleic acids indicate association with angiogenesis
03/27/2003US20030059794 Adenoviral library assay for E2F regulatory genes and methods and compositions for screening compounds
03/27/2003US20030059793 Nucleic acids of the human ABCC11 gene, vectors containing such nucleic acids and uses thereof
03/27/2003US20030059787 Detection of preferential nucleotide sequences coding telomerase; obtain sample containing nucleotide sequences, incubate with probe, detect hybridization product, presence of product indicates gene for telomerase
03/27/2003US20030059785 Detection of markers in nascent proteins
03/27/2003US20030059784 Compositions and methods relating to ovary specific genes and proteins
03/27/2003US20030059783 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/27/2003US20030059782 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of nervous system and cancer diseases
03/27/2003US20030059780 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of nervous system and cancer diseases
03/27/2003US20030059775 Novel proteins and nucleic acids encoding same
03/27/2003US20030059772 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/27/2003US20030059768 Novel polypeptides and nucleic acids encoding same
03/27/2003US20030059767 Zinc finger protein derivatives and methods therefor
03/27/2003US20030059765 Compositions and methods for providing a protein to a virion
03/27/2003US20030059498 A protease and an inner salt of a quaternary amine carboxylic acid for the treatment and/or prophylaxis of coccidiosis and bacterial infections such as necrotic enterities; improved weight gain; poultry; Eimeria
03/27/2003US20030059495 Compositions for appetite control and related methods
03/27/2003US20030059482 Nutritional composition, methods of producing said composition and methods of using said composition
03/27/2003US20030059477 Basic cell growth stimulating factors from a mammal milk product having basic to neutral isoelectric points, enriched with proliferation stimulant of rat myoblasts; wound healing agents for gastrointestinal injuries and skin
03/27/2003US20030059475 Fibrin microbeads and uses thereof
03/27/2003US20030059470 Dispersions for the formulation of slightly or poorly soluble agents
03/27/2003US20030059468 Preparations and processes for stabilizing biological materials by means of drying processes without freezing
03/27/2003US20030059461 Molecular delivery vehicle for delivery of selected compounds to targets
03/27/2003US20030059457 Phaseolamin compositions and methods for using the same
03/27/2003US20030059455 A defective recombinant adenovirus including at least one DNA sequence coding for all or an active part of a superoxide; useful for treating and/or preventing Parkinson's disease, Alzheimer's disease, Huntington's disease etc.
03/27/2003US20030059434 Administering to the subject an effective amount of a chloride channel modulator
03/27/2003US20030059432 Lipophilin complexes for use in cancer diagnosis and therapy
03/27/2003US20030059430 Use of peptides or small molecules in treatment of disease, in high-throughput screening, in use of metal-binding peptides derived from sequences present in CD74-homology domain of insulin-like growth factor
1 ... 1878 1879 1880 1881 1882 1883 1884 1885 1886 1887 1888 1889 1890 1891 1892 1893 1894 1895 1896 1897 1898 ... 3163